Automated signal generation in Prescription-Event Monitoring

Drug Safety

Volumn 25, Issue 6, 2002, Pages 423-432

  Heeley, E ^a   Wilton, L V ^a   Shakir, S A W ^a,b  

^a DRUG SAFETY RESEARCH UNIT   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; DRUG; LAMOTRIGINE; NEUROLEPTIC AGENT; TOLTERODINE;

AUTOMATION; BOOK; CLINICAL TRIAL; CONFERENCE PAPER; DATA ANALYSIS; DATA BASE; DIAGNOSTIC VALUE; DRUG MARKETING; DRUG MONITORING; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; ERYTHEMA MULTIFORME; HALLUCINATION; HUMAN; INCIDENCE; OBSERVATION; POSTMARKETING SURVEILLANCE; PRESCRIPTION; PRIORITY JOURNAL; PROPORTIONAL COUNTER; RASH; SIGNAL DETECTION; STEVENS JOHNSON SYNDROME; UNITED KINGDOM; UPPER RESPIRATORY TRACT INFECTION;

EID: 0036303214     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-200225060-00006     Document Type: Conference Paper

References (10)

1. A Bayesian neural network method for adverse drug reaction signal generation
2. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports
3. Prescription-event monitoring: Recent progress and future horizons
4. Different versions of the anatomical therapeutic chemical classification system and the defined daily dose: Are drug utilisation data comparable?
5. Proportional reporting ratios: The uses of epidemiological methods for signal generation
6. Visual hallucinations associated with fluoxetine and sertraline
7. Psychotic depression
8. Safety profile of tolterodine as used in general practice in England: Results of prescription-event monitoring
9. Adverse drug reactions: Finding the needle in the haystack